Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.11 SAR | 98.24% |
| 2022 | -1.42 SAR | -745.45% |
| 2021 | 0.22 SAR | -78.85% |
| 2020 | 1.04 SAR | 125.94% |
| 2019 | -4.01 SAR | -566.28% |
| 2018 | 0.86 SAR | -47.56% |
| 2017 | 1.64 SAR | -47.77% |
| 2016 | 3.14 SAR | 5.37% |
| 2015 | 2.98 SAR | 1.36% |
| 2014 | 2.94 SAR | 32.43% |
| 2013 | 2.22 SAR | 14.43% |
| 2012 | 1.94 SAR | 10.23% |
| 2011 | 1.76 SAR | 19.73% |
| 2010 | 1.47 SAR | -13.02% |
| 2009 | 1.69 SAR | 20.71% |
| 2008 | 1.40 SAR | 5.26% |
| 2007 | 1.33 SAR | 23.15% |
| 2006 | 1.08 SAR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.33 SAR | 191.67% |
| 2024 Q2 | 0.28 SAR | -15.15% |
| 2023 Q3 | -0.34 SAR | -278.95% |
| 2023 Q1 | 0.46 SAR | 152.87% |
| 2023 FY | - SAR | 98.24% |
| 2023 Q2 | 0.19 SAR | -58.7% |
| 2023 Q4 | -0.36 SAR | -5.88% |
| 2022 FY | - SAR | -745.45% |
| 2022 Q4 | -0.87 SAR | -128.95% |
| 2022 Q3 | -0.38 SAR | 11.63% |
| 2022 Q1 | 0.28 SAR | 177.78% |
| 2022 Q2 | -0.43 SAR | -253.57% |
| 2021 Q4 | -0.36 SAR | -684.42% |
| 2021 Q2 | 0.26 SAR | 18.18% |
| 2021 FY | - SAR | -78.85% |
| 2021 Q3 | 0.06 SAR | -76.31% |
| 2021 Q1 | 0.22 SAR | 300.0% |
| 2020 Q1 | 0.38 SAR | 116.89% |
| 2020 Q3 | 0.56 SAR | 166.67% |
| 2020 FY | - SAR | 125.94% |
| 2020 Q4 | -0.11 SAR | -119.64% |
| 2020 Q2 | 0.21 SAR | -44.74% |
| 2019 Q2 | -1.52 SAR | -1420.0% |
| 2019 FY | - SAR | -566.28% |
| 2019 Q3 | 0.27 SAR | 117.76% |
| 2019 Q4 | -2.25 SAR | -933.33% |
| 2019 Q1 | -0.10 SAR | -190.91% |
| 2018 Q3 | -0.02 SAR | -104.21% |
| 2018 Q1 | 0.46 SAR | 31.43% |
| 2018 FY | - SAR | -47.56% |
| 2018 Q4 | 0.11 SAR | 770.73% |
| 2018 Q2 | 0.39 SAR | -15.22% |
| 2017 Q2 | 0.39 SAR | -53.57% |
| 2017 FY | - SAR | -47.77% |
| 2017 Q3 | 0.07 SAR | -83.08% |
| 2017 Q1 | 0.84 SAR | -52.27% |
| 2017 Q4 | 0.35 SAR | 430.3% |
| 2016 Q3 | 0.06 SAR | -86.91% |
| 2016 Q1 | 0.89 SAR | 1271.05% |
| 2016 FY | - SAR | 5.37% |
| 2016 Q2 | 0.43 SAR | -51.69% |
| 2016 Q4 | 1.76 SAR | 3026.11% |
| 2015 Q2 | 1.98 SAR | 138.55% |
| 2015 Q1 | 0.83 SAR | 9.21% |
| 2015 Q3 | 0.24 SAR | -87.88% |
| 2015 FY | - SAR | 1.36% |
| 2015 Q4 | -0.08 SAR | -131.67% |
| 2014 Q4 | 0.76 SAR | 145.16% |
| 2014 Q3 | 0.31 SAR | -64.37% |
| 2014 Q2 | 0.87 SAR | 14.47% |
| 2014 Q1 | 0.76 SAR | 58.33% |
| 2014 FY | - SAR | 32.43% |
| 2013 Q1 | 0.53 SAR | 17.78% |
| 2013 Q3 | 0.28 SAR | -80.69% |
| 2013 Q4 | 0.48 SAR | 71.43% |
| 2013 FY | - SAR | 14.43% |
| 2013 Q2 | 1.45 SAR | 173.58% |
| 2012 Q4 | 0.45 SAR | 66.67% |
| 2012 FY | - SAR | 10.23% |
| 2012 Q3 | 0.27 SAR | 0.0% |
| 2011 FY | - SAR | 19.73% |
| 2010 FY | - SAR | -13.02% |
| 2009 FY | - SAR | 20.71% |
| 2008 FY | - SAR | 5.26% |
| 2007 FY | - SAR | 23.15% |
| 2006 FY | - SAR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 4.18 SAR | 102.632% |